The story of Viagra, formerly marketed by copyright, presents a fascinating case study for investors considering the healthcare sector. While its initial success and impact of vast in sales, the intellectual property expiration has opened the floodgates for generic medications, greatly diminishing earnings opportunities. This shift raises concer… Read More